Chemistry: molecular biology and microbiology – Enzyme – proenzyme; compositions thereof; process for... – Hydrolase
Patent
1980-09-02
1983-04-26
Shapiro, Lionel M.
Chemistry: molecular biology and microbiology
Enzyme , proenzyme; compositions thereof; process for...
Hydrolase
435212, 424 1, 424 15, 424 2, C12N 972, C12N 948
Patent
active
043813461
ABSTRACT:
The existence of high fibrin-affinity urokinase is discovered by an isolation procedure using fibrin precipitated on an adsorptive-solid matrix. By the method described, the high affinity form of plasminogen activator can be isolated directly from urine or from kidney tissue culture medium. The method is economical and provides a relatively high yield of the activator. The high affinity that this plasminogen activator has for fibrin is a property that makes it an improved thrombolytic agent and when radiolabelled provides a new diagnostic agent for the specific detection of fibrin thrombi through nuclear scanning. The newly-isolated plasminogen activator has the following characteristics: a molecular weight of about 56,000 Daltons, a specific activity of about 40,000-50,000 CTA units/mg, the appearance of a single chain structure and a high affinity for fibrin.
REFERENCES:
patent: 3226304 (1965-12-01), Siiteri et al.
patent: 3234106 (1966-02-01), Hink, Jr. et al.
patent: 4165258 (1975-08-01), Pye et al.
patent: 4258030 (1981-03-01), Sasaki et al.
patent: 4286063 (1981-08-01), Suyama
Gurewich Victor
Huasin Syed S.
Lipinski Boguslaw
LandOfFree
Isolation of plasminogen activators useful as therapeutic and di does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isolation of plasminogen activators useful as therapeutic and di, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolation of plasminogen activators useful as therapeutic and di will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1564825